Provigil Revamped Marketing Campaign To Launch After FDA Cites Promotions
Executive Summary
Cephalon plans to proceed with a new marketing program for Provigil (modafinil) in February after receiving a letter from FDA objecting to many of its current promotional materials for the narcolepsy drug
You may also be interested in...
Cephalon Marketing Under Investigation By Philadelphia U.S. Attorney
The Philadelphia U.S. Attorney's investigation into Cephalon's marketing practices covers the entire commercial life of Provigil
Cephalon Marketing Under Investigation By Philadelphia U.S. Attorney
The Philadelphia U.S. Attorney's investigation into Cephalon's marketing practices covers the entire commercial life of Provigil
FDA Drug Safety Upgrades Coming; Medicare Bill Could Help Win Funding
The Medicare prescription drug coverage legislation should help FDA make the case for additional funding for post-marketing surveillance, according to Center for Drug Evaluation & Research Acting Director Steven Galson, MD